Northwest Wealth Management LLC Invests $282,000 in Centene Corporation (NYSE:CNC)

Northwest Wealth Management LLC acquired a new position in shares of Centene Corporation (NYSE:CNC - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,652 shares of the company's stock, valued at approximately $282,000.

Other large investors also recently added to or reduced their stakes in the company. Pinney & Scofield Inc. purchased a new position in shares of Centene during the fourth quarter valued at about $25,000. Hurley Capital LLC bought a new stake in Centene during the fourth quarter worth about $26,000. Ameriflex Group Inc. bought a new stake in Centene during the fourth quarter worth about $26,000. Rialto Wealth Management LLC bought a new stake in Centene during the fourth quarter worth about $30,000. Finally, Studio Investment Management LLC bought a new position in shares of Centene in the fourth quarter worth approximately $32,000. Hedge funds and other institutional investors own 93.63% of the company's stock.

Centene Trading Up 0.8%

Shares of CNC opened at $53.98 on Monday. Centene Corporation has a 1-year low of $52.93 and a 1-year high of $80.59. The company has a 50-day moving average of $57.69 and a 200 day moving average of $59.63. The firm has a market capitalization of $26.86 billion, a price-to-earnings ratio of 8.04, a PEG ratio of 0.65 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.11 and a quick ratio of 1.11.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, beating analysts' consensus estimates of $2.52 by $0.38. The company had revenue of $46.62 billion during the quarter, compared to analyst estimates of $43.16 billion. Centene had a net margin of 2.04% and a return on equity of 14.56%. The firm's revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter last year, the business posted $2.26 EPS. On average, research analysts expect that Centene Corporation will post 6.86 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently issued reports on CNC. Robert W. Baird dropped their target price on shares of Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Barclays reaffirmed an "equal weight" rating and set a $65.00 target price (down from $84.00) on shares of Centene in a report on Monday, June 2nd. Guggenheim reissued a "neutral" rating on shares of Centene in a research note on Tuesday, April 29th. Jefferies Financial Group dropped their target price on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research report on Tuesday, April 29th. Finally, Wall Street Zen lowered shares of Centene from a "strong-buy" rating to a "buy" rating in a research report on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, Centene has an average rating of "Moderate Buy" and a consensus target price of $77.71.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.